Pure Global

SARS-CoV-2 Antigen Test Kit - India CDSCO Medical Device Registration

SARS-CoV-2 Antigen Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000290_6e3009cd090d7d12638276efe9c8abc5_be68a53de5e71e6ae0c211863264b2d3. This device is marketed under the brand name LFIA. The license holder is Regulatory1, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
SARS-CoV-2 Antigen Test Kit
UID: IMP/IVD/2021/000290_6e3009cd090d7d12638276efe9c8abc5_be68a53de5e71e6ae0c211863264b2d3

Brand Name

LFIA

License Holder

Regulatory1

Device Class

Class C

Approving Authority

CDSCO

Product Information

SARS-CoV-2 antigen Test Kit (LFIA) is used to qualitatively detect SARS-CoV-2 inhuman samples in vitro.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Other Products from Regulatory1
Products from the same license holder (2 products)